Skip to main content
. 2021 Feb 9;23(9):1494–1508. doi: 10.1093/neuonc/noab023

Fig. 1.

Fig. 1

Fig. 1

Genome-wide DNA methylation profile of serum cell-free DNA (cfDNA) from patients with glioma. (A) Principal component analysis of serum-based cfDNA methylation. (B) Cell-type-specific CpG methylation-based deconvolution. (C) Published tissue-derived epigenetic signatures are shown as a heatmap.